ORAMED PHARMACEUTICALS INC. - 30 Jun 2025 SCHEDULE 13G/A Report for Scilex Holding Co Common Stock par value $0.0001 per share (SCLX)

Filing Manager: ORAMED PHARMACEUTICALS INC.
Reporting Manager: Oramed Pharmaceuticals Inc.
Security: Scilex Holding Co Common Stock par value $0.0001 per share
Symbol: SCLX
Shares outstanding: 7.72M shares
Disclosed Ownership: 764K shares
Ownership: 9.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 18:56:40 UTC
Date of event: 30 Jun 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Oramed Pharmaceuticals Inc.	9.9%	764K	764K	0	/s/ Avraham Gabay	Avraham Gabay, Chief Financial Officer